Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
2(40%)
Results Posted
100%(2 trials)
Terminated
1(20%)

Phase Distribution

Ph phase_1
1
20%
Ph phase_2
4
80%

Phase Distribution

1

Early Stage

4

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
4(80.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

2

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Completed(2)
Terminated(1)

Detailed Status

Completed2
Recruiting2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
2
Success Rate
66.7%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (20.0%)
Phase 24 (80.0%)

Trials by Status

completed240%
recruiting240%
terminated120%

Recent Activity

2 active trials
Showing 5 of 5
recruitingphase_2

Randomised Treatment of Acute Pancreatitis With Infliximab: Double-blind, Placebo-controlled, Multi-centre Trial (RAPID-I)

NCT03684278
recruitingphase_2

Lumasiran in Hyperoxalaemic Patients on Haemodialysis

NCT06225544
completedphase_1

Safety and Protective Efficacy of Intravenous Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chemoprophylaxis

NCT02115516
terminatedphase_2

Study in Hepatitis C Virus (HCV) Infected Patients Undergoing Liver Transplantation to Evaluate a Human Monoclonal Antibody Against Hepatitis C

NCT01121185
completedphase_2

Prevention of Acute Kidney Injury in Cardiac Surgery Patients

NCT00921518

Clinical Trials (5)

Showing 5 of 5 trials
NCT03684278Phase 2

Randomised Treatment of Acute Pancreatitis With Infliximab: Double-blind, Placebo-controlled, Multi-centre Trial (RAPID-I)

Recruiting
NCT06225544Phase 2

Lumasiran in Hyperoxalaemic Patients on Haemodialysis

Recruiting
NCT02115516Phase 1

Safety and Protective Efficacy of Intravenous Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chemoprophylaxis

Completed
NCT01121185Phase 2

Study in Hepatitis C Virus (HCV) Infected Patients Undergoing Liver Transplantation to Evaluate a Human Monoclonal Antibody Against Hepatitis C

Terminated
NCT00921518Phase 2

Prevention of Acute Kidney Injury in Cardiac Surgery Patients

Completed

All 5 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
5